STAT3, also called acute-phase response factor, has been implicated in inflammatory signaling, inhibition of apoptosis, glucose homeostasis, hyperleptinemia, and hepatic steatosis [67], [68], [69], [70]. Here, STAT3 is linked to fatty liver disease.